Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Automated Microbial Diagnostics

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A randomised, placebo-controlled phase 3 study to evaluate the efficacy and safety of ASP0113, a DNA-based CMV vaccine, in seropositive allogeneic haematopoietic cell transplant recipients.

EClinicalMedicine·2021

Same author

Pharmacokinetics and Immunogenicity of ASP0113 in CMV-Seronegative Dialysis Patients and CMV-Seronegative and -Seropositive Healthy Subjects.

Clinical pharmacology in drug development·2020

Same author

First-in-Human Phase 1 Study To Assess Safety, Tolerability, and Pharmacokinetics of a Novel Antifungal Drug, VL-2397, in Healthy Adults.

Antimicrobial agents and chemotherapy·2019

Same author

The Siderophore Transporter Sit1 Determines Susceptibility to the Antifungal VL-2397.

Antimicrobial agents and chemotherapy·2019

Same author

Population Pharmacokinetic Modeling of VL-2397, a Novel Systemic Antifungal Agent: Analysis of a Single- and Multiple-Ascending-Dose Study in Healthy Subjects.

Antimicrobial agents and chemotherapy·2019

Same author

A cytomegalovirus DNA vaccine induces antibodies that block viral entry into fibroblasts and epithelial cells.

Vaccine·2015

Search research articles

Related Experiment Video

Updated: Jul 16, 2026

Optimization of a Quantitative Micro-neutralization Assay

Optimization of a Quantitative Micro-neutralization Assay

Published on: December 14, 2016

Novel microneutralization assay for HCMV using automated data collection and analysis.

Anna Maria Abai¹, Larry R Smith, Mary K Wloch

¹Vical Inc., 10390 Pacific Center Court, San Diego, California 92121, USA. a_abai@hotmail.com

Journal of Immunological Methods

|March 9, 2007

Summary

A new 96-well microplate assay accurately measures human cytomegalovirus (HCMV) neutralizing antibody activity in serum. This automated assay is suitable for high-volume screening of clinical trial samples.

More Related Videos

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System

Published on: October 5, 2015

Automation of the Micronucleus Assay Using Imaging Flow Cytometry and Artificial Intelligence

Automation of the Micronucleus Assay Using Imaging Flow Cytometry and Artificial Intelligence

Published on: January 27, 2023

Related Experiment Videos

Last Updated: Jul 16, 2026

Optimization of a Quantitative Micro-neutralization Assay

Optimization of a Quantitative Micro-neutralization Assay

Published on: December 14, 2016

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System

Published on: October 5, 2015

Automation of the Micronucleus Assay Using Imaging Flow Cytometry and Artificial Intelligence

Automation of the Micronucleus Assay Using Imaging Flow Cytometry and Artificial Intelligence

Published on: January 27, 2023

Area of Science:

Virology
Immunology
Assay Development

Background:

Assessing neutralizing antibody activity is crucial for vaccine development.
Existing assays may not be suitable for high-volume screening of clinical trial samples.
Automation and efficiency are key requirements for clinical assay implementation.

Purpose of the Study:

To develop and optimize a 96-well microplate assay for measuring human cytomegalovirus (HCMV) neutralizing antibody activity.
To adapt the assay for high-volume screening of clinical trial samples.
To ensure the assay is sensitive, specific, automated, and reproducible.

Main Methods:

Utilized HEL-299 cells and HCMV strain AD169 in a 96-well microplate format.
Quantified infected cell nuclei via IE1 protein expression using immunoperoxidase staining.
Employed an automated ELISPOT analyzer for nuclei counting and specialized software for data analysis.

Main Results:

Developed a sensitive, specific, and reproducible assay for HCMV-neutralizing activity.
Half Area 96-well microplates improved signal detection and reduced reagent usage.
Automated staining and data analysis streamlined the process and accelerated results.

Conclusions:

The developed assay is fast, convenient, and suitable for high-volume screening of HCMV-neutralizing antibodies in human sera.
This assay is applicable for evaluating vaccine efficacy in clinical trials, such as those involving HCMV pDNA vaccines.
The assay's characteristics meet the requirements for assessing neutralizing antibody responses in vaccine recipients.